The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant
Year: 2021
Type: review
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Novartis Pharma
OpenAlex ID: W3142931815
